BenzingaOctober 27, 2026 at 4:34 AM NY10 Hours Ago
Argus Research Downgrades Abbott Laboratories to Hold
Argus Research analyst David Round downgrades Abbott Laboratories (NYSE:ABT) from Buy to Hold.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga